Status:
COMPLETED
Screen to Save 2: Rural Cancer Screening Educational Intervention
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Dartmouth College
Conditions:
Cancer
Colorectal Cancer
Eligibility:
All Genders
45-75 years
Phase:
NA
Brief Summary
The purpose of this study is to help the Dartmouth Cancer Center and the National Cancer Institute understand how to educate people about cancer screening.
Detailed Description
The Dartmouth Cancer Center's Community Outreach and Engagement Team will implement Screen to Save 2 in two formats-traditional outreach using in-person fairs and an online format. The education in bo...
Eligibility Criteria
Inclusion
- Inclusion Criteria for study arms 1-4:
- Resident of one of the RUCC 7-9 counties in New Hampshire or Vermont (Coos or Sullivan County, NH; Caledonia, Windsor, Windham, Orange, Orleans, Lamoille, or Essex County, VT) and
- Age 45-74 at the time of enrollment in the study
- Additional Inclusion Criteria for study arm 4:
- \- Any New Hampshire or Vermont residents age 45-75
Exclusion
- \- Cognitive impairment preventing participation in informed consent process
- Three-Month Follow-Up Survey Inclusion Criteria:
- A participant will be eligible for inclusion in the three-month follow-up survey if the participant completed the pre-test, educational intervention, and post-test (in-person or through online submission) and at the time of initial participation:
- Answered a colorectal cancer screening history question indicating that the participant has never received colorectal cancer screening OR does not know if he/she has received colorectal cancer screening previously OR
- Answered a series of questions indicating that the participant received prior colorectal cancer screening but may be overdue for colorectal cancer screening based on the type of colorectal cancer screening last reported and screening guidelines for the frequency of re-screening.
- Six-Month Follow-Up Survey Inclusion Criteria:
- A participant will be eligible for inclusion in the six-month follow-up survey if the participant participated in the three-month-follow up survey and at that time reported that having:
- A FIT/FOBT screening or Cologuard (stool) screening performed since the time of initial study participation, but having not received the results
- An abnormal FIT/FOBT, or Cologuard (stool) screening since the time of initial study participation, but had not received a diagnostic colonoscopy
- A colonoscopy since the time of initial study participation, but had not received the final results
Key Trial Info
Start Date :
October 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
382 Patients enrolled
Trial Details
Trial ID
NCT04414306
Start Date
October 8 2020
End Date
November 30 2023
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth Cancer Center
Lebanon, New Hampshire, United States, 03756